Sarepta Therapeutics, Inc. SRPT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q1 '25 | TTM Q4 '24 | TTM Q3 '24 | ||
|---|---|---|---|---|---|---|
| $2.18B— | $2.2B— | —— | —— | $1.64B+48.5% | ||
| —— | —— | -$248.39M-764% | $235.24M+140% | $76.19M+111% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sarepta Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Sarepta Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.